The trajectory of Sildenafil presents a intricate picture for those considering investment. While the initial release generated substantial returns, the expiration of its patent opened the floodgates to cheaper competitors, dramatically diminishing market share. This presents a unique risk for drug manufacturers relying on similar blockbuster medic

The history of Viagra, and its developer copyright, presents a intriguing case study for investors. Initially a blockbuster drug, producing billions in income, its intellectual property lapse created a deluge of generic competition , significantly diminishing its more info market share . While specific pharmaceutical companies may seek to capitaliz